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Technical note for Ebola virus disease preparedness planning for entry screening at 
airports, ports and land crossings 
Introduction 
In August 2014, the WHO Director-General declared the Ebola virus disease (EVD) outbreak in West Africa a 
Public Health Emergency of International Concern, under the provisions of the International Health Regulations 
(IHR) 2005.  The IHR Emergency Committee advised non-affected countries to establish and strengthen 
surveillance for clusters of unexplained fever or deaths due to febrile illness. It also advised countries to prepare 
to detect, investigate and manage EVD cases to minimize the risk of international spread of the disease, while 
avoiding general bans on international travel and trade.   
 
WHO does not recommend entry screening at this time for the EVD outbreak in West Africa. However, for 
preparedness planning purposes, countries may wish to develop plans and procedures for entry screening 
according to their own risk assessment and cost benefit analysis. Entry screening procedures should not interfere 
with international travel and trade.  
 
This document provides recommendations for planning entry screening at Points of Entry (PoE). It was developed 
in collaboration with the US Centers for Disease Control and Prevention, the International Civil Aviation 
Organization and the International Air Transport Association.  
 
Background 
The incubation period of EVD, from exposure to the onset of symptoms, ranges between 2 and 21 days. People 
without symptoms of EVD are not able to spread the disease. The principal mode of transmission is direct contact 
with the body fluids of people who have symptoms. 
 
Travellers have previously been diagnosed with haemorrhagic fever diseases (Ebola, Marburg, or Lassa fever) 
after long-distance travel (e.g., between continents). To date, there have been no reports of virus transmission 
during travel. However, transmission has occurred in destination countries after travel, such as in health-care 
facilities, when recommended infection prevention and control precautions were not appropriately followed.  
 
Objectives of entry screening planning 
An entry screening plan usually has stated objectives, such as: 
 to identify upon arrival international travellers exhibiting signs and symptoms of EVD, or with a history of 
exposure to Ebola virus, and provide an effective, coordinated response to protect the health of 
travellers and communities;  
 to provide procedures and requirements needed to screen travellers at airports or other PoE (e.g., ports 
or ground crossings); 
 to include entry screening in a comprehensive approach to disease prevention, treatment and care. 
 
Objectives of entry screening  
 To identify ill travelers with signs and symptoms consistent with EVD, and their potential contacts; 
 to identify appropriate public health measures, such as treatment and isolation,  that are commensurate  
with the risks and do not unduly interfere with international travel; 
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Planning for entry screening  
 
1. Coordination of entry screening with other public health measures  
Entry screening is most effective when accompanied by other interventions such as exit screening in Ebola-
affected countries, health alert notices, and reporting identified ill travellers to public health authorities upon 
arrival. Consideration should be given to the best use of available resources, the capacity to conduct entry 
screening, and the number of travellers arriving from affected countries. 
 
Health authorities may coordinate with airlines to ensure there is adequate time for passengers in transit to 
board their departing flights. This is to avoid hasty screening and passengers missing their connecting flights. 
Passengers in transit may be screened in a priority line. 
 
2. Communications 
2.1 Communication with travellers 
Information on the potential risk of EVD may be provided at PoE (e.g. at airports or ports), in arrival areas or at 
ground crossing points, to raise the awareness and knowledge of travellers. 
Travellers should be informed of the measures to take should they develop symptoms of EVD, and how they can 
obtain assistance. Airlines should consider educating travellers onboard about EVD and the procedures they may 
undergo upon arrival (see Appendix 2 for sample scripts) 1.   
Template message for travellers  
 
 Infection occurs through contact with the blood, body fluids or tissues of an infected symptomatic 
person, or the body of a person who has died from Ebola, or by contact with contaminated objects.  
 Persons who come into direct contact with an infected symptomatic person or infected animal or the 
body of a person who has died from Ebola are at risk.  
 Avoid all contact with blood, body fluids, and tissues of sick people, even after their death.  
 Do not handle items that may have been in contact with an infected person.  
 Symptoms include fever, weakness, muscle pain, headache and sore throat. This is followed by vomiting, 
diarrhoea, rash, and, in some cases, bleeding.  
 In the most affected countries of Guinea, Liberia and Sierra Leone, particular care should be taken to 
avoid EVD infection.  
 Simply being in proximity to a healthy-looking person (for example, in a public transport conveyance) 
does not constitute a risk.  
 There is no approved vaccine.  
 Practise careful hygiene, especially hand hygiene with an alcohol-based handrub solution (hand sanitizer) 
if available, and with soap and water when hands are visibly soiled. Practise hand hygiene especially 
before touching eyes, nose or mouth, and after using the toilet or touching objects at high risk of being 
contaminated.  
 If you stayed in the areas where Ebola cases have been recently reported, seek immediate medical 
attention if you feel ill (fever, headache, achiness, sore throat, diarrhoea, vomiting, stomach pain, rash or 
red eyes). Early treatment improves the chance of recovery. 
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 Do not take aspirin or ibuprofen because they can increase the risk of bleeding. This information should 
also be given to all passengers during exit screening. 
 
2.2 Communication between Points of Entry and national health surveillance systems 
 Promptly establish lines of communication between PoE health authorities and transport sector officials 
(e.g. representatives of the national civil aviation and maritime authorities, conveyance operators and 
PoE operators), as well as those between PoE health authorities and the national health surveillance 
systems. 
 Raise awareness of EVD and disseminate information among all relevant stakeholders at PoE.  
 Establish and improve procedures and means of communication for:  
a) PoE health authorities receiving health information, documents, and/or reports from conveyance 
operators regarding ill travellers on board, and to provide advice and advance notice of application of 
control measures;  
b) PoE health authorities to inform the next PoE of ill travellers on board;  
c) PoE health authorities to inform the national health surveillance system of ill travellers identified.  
 
 
3.  Public health documents 
The International Health Regulations require the following documents to be used to collect information about 
potential public health risks. To improve the detection of EVD at PoE, these documents could assist in the 
collection of information about ill travellers with clinical signs or symptoms consistent with EVD. 
 
3.1 Air travel: Health section of the Aircraft General Declaration Form 
If the health section of the Aircraft General Declaration Form is not required for all arriving aircraft, the country 
may consider making its submission mandatory for aircraft arriving from EVD-affected areas and for aircraft 
carrying ill travellers suspected of having EVD. The State Party shall inform aircraft operators or their agents of 
these requirements. 
 
3.2 Sea travel: Maritime Declaration of Health and Ship Sanitation Certificates  
     a) If the Maritime Declaration of Health is not required for all arriving ships on an international voyage, the 
country may consider making its submission mandatory for international ships arriving from/passing through 
EVD-affected areas, particularly ships carrying ill travellers suspected of having EVD. 
      b) Any public health measures adopted on board should be recorded on Ship Sanitation Certificates. This 
includes the examination of crew or travellers who have been in Ebola-affected areas and need to be followed up 
at the next port.  Coordination with IHR National Focal Points among the countries is needed to transmit 




4. Identification of Points of Entry and travellers to be screened  
The following factors need to be considered when planning entry screening. 
4.1 Identification of conveyances: 
 arriving directly from affected countries, their routes and PoE;  
 arriving indirectly after stopping at some point in affected countries, their routes and PoE; 
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 carrying travellers with signs and symptoms consistent with EVD, or known to have recently been in an 
Ebola-affected area, based on information provided in the public health documents listed above, or to 
the competent authority at PoE prior to arrival. 
4.2 Identification of travellers based on information obtained prior to arrival 
Travellers’ itineraries, potential exposure history and other information obtained prior to arrival at the 
destination country may assist in identifying travellers suitable for screening. This could reduce indiscriminate 
screening of travellers arriving at PoE, and increase the likelihood of travellers cooperating. 
For countries sharing borders with Ebola-affected countries, entry screening could be warranted at all land 
crossing points, if the affected country does not conduct exit screening. Countries that share borders may also 
consider entering into agreements that aim to prevent and control international transmission of EVD at ground 
crossings.  Joint designation of adjacent ground crossings could also be considered.  
 
5. Personal Protective Equipment (PPE)  
To protect screening personnel, PPE guidance may be emphasized as follows: 
 
All staff involved in the screening and transfer of EVD patients must comply with their organization’s health 
and safety policies.  Staff involved in traveller screening or responding to suspected EVD cases at PoE will 
follow country protocols and procedures.  
 
Other considerations include:  
o Planning to ensure there is sufficient PPE to support the response (e.g. port health agencies maintain a 
four-week supply of PPEs for every responder, and inventory PPE stock for needed supplies every two 
weeks).  
o Holding   training on proper donning and doffing (putting on and removing) of PPE before screening is 
implemented.  
 
6. Staffing requirements 
Staffing needs for entry screening are based on an estimation of the number of travellers to be screened on 
arrival identified in the planning phase; the layout of airports or port terminals; the location of secondary 
screening; and the number of arriving conveyances. In general, port health officers are placed in each airport 
terminal for secondary screening. Multiple work shifts may be required. Shifts should be coordinated around the 
arrival times of flights targeted for screening.   
 
7. Implementation timeline 
The agencies implementing and supporting screening need to know when staff should be prepared to perform 
these functions. Agencies should consider the time it takes to identify qualified personnel or to provide training. 
Administrative requirements for people to become qualified to conduct screening should also be considered, 
along with the time required to set up facilities and procure supplies to support screening. 
 
The implementation of entry screening requires:  
 
 the selection of the necessary response staff;  
 obtaining PoE security clearance for badges and access;  
 training staff and partners;  
 securing local government and organization support; and 
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8. Legal context  
The IHR provide options for health measures and the legal context for their application (IHR articles 15-18, 23-
34). The implementation of entry screening and/or restrictions on persons from affected areas can be 
implemented with the following public health measures:  
 reviewing travel history in affected areas; 
 reviewing  proof of medical examination and any laboratory analysis; 
 requiring  medical examinations; 
 placing suspect persons under public health observation; 
 implementing quarantine or other public health measures for suspect persons; 
 implementing isolation and treatment of affected persons when necessary; 
 implementing contact tracing  of suspect or affected persons. 
 
According to IHR Article 31.2, if a traveller for whom a country may require a medical examination, vaccination or 
other prophylaxis fails to consent to any such measure, or refuses to provide the information or the documents, 
the country concerned may deny entry to that traveller. If there is evidence of an imminent public health risk, the 
country may, in accordance with its national law and to the extent necessary to control such a risk, compel or 
advise the traveller to undergo: 
(a) the least invasive and intrusive medical examination that would achieve the public health objective; 
(b) vaccination or other prophylaxis; or 
(c) additional established health measures that prevent or control the spread of disease, including isolation, 
quarantine or placing the traveller under public health observation. 
 
Countries adopting measures that significantly interfere with international air traffic, such as refusing 
international travellers entry or departure for more than 24 hours, shall inform WHO of such measures and their 
public health rationale within 48 hours of implementation (Article 43). WHO has a mandate to share such 
information with all State Parties. 
 
Overview of Entry Screening Operations 
Entry screening is a two-stage process, including primary and secondary screening. Primary screening can be 
conducted by staff without medical or public health training. Its purpose is to identify travellers who could be at 
risk of EVD, either due to symptoms or exposure history. Secondary screening is a more detailed process usually 
conducted by staff with medical or public health training. Its purpose is to identify travellers with symptoms or 
exposure history requiring further evaluation. 
1. Communications 
Entry screening implementation should include a comprehensive public health communications campaign to 
educate the community, travellers and the travel industry.  These messages should include important health 
information about actions that travellers should take if they feel ill after travel or if they have been exposed to 
Ebola. Travellers should be reminded to be prepared for delays that may occur as a result of entry screening. 
2. Legal Mechanisms for Screening and Other Interventions 
Any plan for entry screening should include consideration of the legal mechanisms to conduct screening and 
related activities, and the responsible authorities. Interventions that may require legal authority include primary 
and secondary screening for travellers; medical evaluation for symptomatic travellers; and public health 
interventions such as symptom monitoring, public health observation, quarantine, and possible travel restrictions 
for exposed travellers. Planners should gain consent and support for these activities from other government 
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3. Plan of Operations  
Entry screening should be implemented, taking into account the PoE public health emergency plan. Modify and 
adopt existing public health emergency plans according to the situation. Note the core capacity requirements 
that should be in place:  
(a) to provide appropriate public health emergency response by establishing and maintaining a public health 
emergency contingency plan, including the nomination of a coordinator and contact points for relevant PoE, 
public health and other agencies and services; 
(b) to provide assessment of and care for affected travellers or animals by establishing arrangements with local 
medical and veterinary facilities for their isolation, treatment and other support services that may be required; 
(c) to provide appropriate space, separate from other travellers, to interview suspect or affected persons; 
(d) to provide for the assessment and, if required, quarantine of suspect travellers, preferably in facilities away 
from the PoE; 
(e) to apply recommended measures to disinfect, decontaminate or otherwise treat baggage, cargo, containers, 
conveyances, goods or postal parcels including, when appropriate, at locations specially designated and equipped 
for this purpose; 
(f) to apply entry or exit controls for arriving and departing travellers; and 
(g) to provide access to specially designated equipment, and to trained personnel with appropriate personal 
protection, for the transfer of travellers who may carry infection or contamination. 
 
4. Primary Screening 
Primary screening includes temperature measurement and visual observation of travellers to look for signs of 
illness. Screening personnel also review Traveller Public Health Declaration Forms (Appendix 3).  Travellers who 
have signs or symptoms of Ebola, or who have been potentially exposed to the virus, are referred to secondary 
screening.  
 
Operational considerations for primary screening: 
o Set up a physical space for travellers to fill out a Traveller Public Health Declaration Form for primary 
screening as soon as they arrive at the PoE, or make arrangements for the health declaration forms and 
the passenger locator cards to be completed on the conveyance. 
o Select and train port staff to conduct visual screening of travellers. Primary screening staff do not need 
medical or public health training. 
o Use appropriate personal protective equipment (PPE) when assessing ill travelers.  
o Choose security personnel to provide crowd control. 
o Select PoE workers to limit access to primary screening areas. 
o Ensure thermometers are calibrated and tested periodically for accuracy.  
o Select escorts for ill travellers or potentially exposed travellers, to take them to secondary screening. 
o Determine baggage assistance and security requirements for travellers referred to secondary screening. 
o Take into consideration the sensitivity of temperature measurement equipment. The temperature cut-
off point for further evaluation (secondary screening) should be lower than 38.6° C to correct sensitivity 
variations.  
 
5. Secondary Screening 
Staff with medical or public health training conduct secondary screening. Screening staff assess travellers for 
signs or symptoms of EVD based on the most current case definition and known risk factors for exposure to Ebola 
virus. Travellers have their temperature taken using a non-contact thermometer.  Travellers are also checked for 
other symptoms of Ebola. Screening staff interview travellers using questionnaires for secondary screening 
(Appendix 4). Health authorities at PoE and other public health officials decide when travellers can be released 
from screening to continue to their next destination, or if they should be referred to a health-care facility for 
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Operational considerations for secondary screening: 
 
o Select and train staff to conduct secondary screening of travellers, as needed.  Secondary screening 
staff should have some medical or public health training. 
o Identify staff to train port officers on EVD symptom screening and procedures, to report possible EVD 
cases. 
o Use appropriate PPE when assessing ill travellers.  
o Purchase non-contact thermometers and train staff to use them. 
o Develop questionnaires for secondary screening and train staff to use them.   
o Develop guidance for staff on assessing travellers for signs and symptoms consistent with EVD including 
fever, severe headache, muscle pain, vomiting, diarrhoea, stomach pain, and/or unexplained bleeding 
or bruising.  
o Develop a process to refer exposed travellers without EVD symptoms, including travel companions of 
symptomatic travellers with suspected EVD, to public health authorities for interventions such as 
symptom monitoring when needed. 
o Locate and secure temporary space to isolate ill travellers until further evaluation can be arranged.  
o Prepare educational material for ill or exposed travellers. 
 
6. Transfer to Health-care Facilities 
Emergency medical service personnel will arrange or provide transport for ill persons to health-care facilities 
for medical evaluation, diagnosis and medical care. Other considerations include: 
 
o identifying medical facilities for evaluation of ill travellers; 
o ensuring patient transport (by ambulance) is available, when needed;  
o ensuring  infection prevention and control precautions are in place, PPE is available, and staff are 
trained in its correct use  (for EVD, this includes gown, gloves, mask, and eye protection); 
o establishing a process to inform local clinics or hospitals prior to patient transfer; 
o addressing security issues during transportation. 
 
Data Management 
Data management refers to the process of storing, recording, and disposing of the records captured during entry 
screening. This may include paper-based record-keeping and/or electronic database creation and data entry, 
depending upon the resources and infrastructure available. 
 
Appropriate management of data as part of an entry screening plan provides valuable insight into the scope and 
effectiveness of screening programs. This information helps to inform future decision-making and 
implementation considerations.  
 
The templates suggested to assist in data collection can be found in Appendices 3 to 7. 
Checklist for Entry Screening plans often include tools to assist in evaluating implementation. An example is 
found in Appendix 1. 
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Appendix 1: Sample Entry Screening Checklist 
  
Entry Screening is a public health intervention used to identify persons with possible symptoms of, or 
risk of exposure to, Ebola virus disease (EVD), to prevent them from further travel. Screening measures 
are based upon risk and can be adapted for airports, land border crossings and sea ports.  
 
Primary Screening:  Identified travellers with signs, symptoms or risk of exposure to Ebola. 
 
Prior to Implementation: 
 Develop Standard Operating Procedures (SOP) for primary screening for ports 
 Develop SOP for all staff on the proper use of Personal Protective Equipment (PPE) 
 Identify:  
 the Points of Entry (PoE) where primary screening will be implemented 
 the appropriate location(s) where primary screening will take place within each PoE 
 Identify staffing needs for: 
 screening personnel 
 security 
 transportation (for possible referrals for further medical evaluation) 
 Train personnel on: 
 primary screening procedures including use of a Traveller Public Health Declaration Form 
 appropriate use of PPE 
 Develop a Traveller Public Health Declaration Form to screen for potential EVD exposure or 
infection (see Appendix 3)  
 Translate the Traveller Public Health Declaration Form into relevant languages 
 Identify data management needs and protocols  
 Develop a communication campaign to educate travellers and the travel industry about the entry 
screening process (e.g. posters, signs, or other educational media) 
 Develop/distribute communication tools such as travel health notices to provide general 
information on the outbreak, the purpose of screening and potential impacts on travellers, the 
travel industry and others 
 
Implementation: 
 Implement SOP for primary screening 
 Follow PPE guidance for screening staff 
 Observe travellers for signs and symptoms of disease 
 Distribute and collect Traveller Public Health Declaration Forms on EVD exposure or 
infection 
 Execute the data management strategy 
 Post and distribute communication tools 
 
 Travellers may proceed with travel if it is determined through primary screening that they have no 
exposure risk based on their health declaration and no relevant symptoms.   
 If travellers have answered yes to any of the questions on the Traveller Public Health Declaration 
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Secondary Screening:  Further assessment of identified travellers to determine if travel restriction or 
referral for medical evaluation is needed. 
 
Prior to Implementation: 
 Develop SOPs for secondary screening for airports, ports and ground crossings 
 Develop public health interview for enhanced assessment (Appendix 4)  
 Identify:  
 PoE where secondary entry screening will be implemented  
 appropriate location for secondary screening to take place within each PoE 
 a location to  keep travel companions and others who have touched a symptomatic individual 
or their body fluids, until they are released for travel   
 Identify staffing needs for: 
 Screening  
 Medical and public health  needs 
 Security 
 Transportation (for possible referrals for further medical evaluation) 
 Train personnel in: 
 the use of the enhanced assessment tool 
 secondary screening procedures 
 the use of infrared non-contact thermometers 
 the appropriate use of PPE 
 Procure appropriate supplies needed for temperature screening 
 Develop a public health interview for enhanced assessment  
 Translate public health interview questions into relevant languages 
 Identify data management needs and protocols (e.g. secondary screening logs) 




 Implement Secondary screening SOP 
 Follow PPE guidance for screeners 
 Evaluate passenger for signs and symptoms of disease 
 Conduct an enhanced public health interview (Appendix 4) 
 Conduct temperature screening  
 Execute implementation strategy 
 
 The traveller may proceed with travel if it is determined through secondary screening that they do not 
meet the risk criteria, based on the health questionnaire, and do not have signs and symptoms of 
disease. 
 Referral for additional medical evaluation may be recommended based on secondary screening.  
 
Referral to Public Health or Medical Authorities 
 
Prior to Implementation: 
 Develop SOP for referral to public health or medical authorities  
 (May be included in secondary screening SOP) 
 Identify how travellers will be transferred to public health authorities for assessment or 
transported to a medical facility for care 
 Identify the transport service provider 
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 Identify security personnel to assist with non-compliant travellers 
 Identify notification procedures to public health or medical authorities for all referrals 
 Identify criteria to add or remove travellers from the travel restriction list and notify travellers of 
the requirements to continue travel 
 
Implementation: 
 Transport the traveller to the medical facility 
 Notify the appropriate public health authority 
 Place any traveller referred for further assessment on the travel restriction list 
 
Potential Legal Authorities 
 International Health Regulations/Public Health Emergency of International Concern 
recommendations: international regulations that facilitate international cooperation to mitigate the 
spread of disease 
 National authorities (country specific) 
 Local authorities (country specific) 
 
Communication: to educate travellers and the travel industry about the entry screening process 
 Message to travellers: 
o Passengers determined to have symptoms consistent with, or to have had possible 
exposure to, EVD should expect delays 
o Travellers with EVD symptoms will be denied travel 
o Where to get care if denied travel 
o Postpone travel when sick 
 Messages to industry: 
o Requirements for information from travellers 
o Reporting of ill travellers 
o Response to ill travellers 
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Appendix 2:  Script to be read by cabin crew to passengers prior to arrival  
 
Script 1: When arriving at a country where travellers from affected countries are asked to self-identify to the 
public health authority.  
 
Ladies and gentlemen,  
Actions have been put in place by public health authorities in response to the ongoing outbreak of Ebola in Guinea, 
Liberia, and Sierra Leone.  
All travellers (including transit travellers) who have been present in Guinea, Liberia, and Sierra Leone, in the past 
three weeks are asked to report to the public health authority on arrival at the airport. This is requested as a safety 




Script 2: When arriving at a country that requires passengers to fill out the Traveller Health Declaration Form.  
 
Ladies and gentlemen,  
Actions have been put in place by public health authorities in response to the ongoing outbreak of Ebola in Guinea, 
Liberia, and Sierra Leone.  
Public health authorities require that all travellers complete a health declaration form before arrival. Your 
information will be used in accordance with local privacy laws to help fight the spread of the disease. Every 
traveller must complete a form. A parent or guardian may complete the form for a child. This is required as a 
precautionary measure, even if you are feeling well.  
The cabin crew will give out the form shortly. Please hand the completed form to the public health authority 
representative on arrival. 
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Appendix 3:  Template Traveller Public Health Declaration Form 
If entry screening is implemented at the Points of Entry in your country, it is highly recommended that 
public health authorities use the template below. The application of a unified form will facilitate 
harmonization of international practice and procedures for primary traveller health screening at Points of 
Entry during the Ebola outbreak. 
Please complete this form. The information is being collected as part of the public health response to the 
outbreaks of Ebola in West Africa. The information will be used by public health authorities in accordance 
with applicable national laws. 
Last (family) name: ……..……..……..…….….…. First (given) name: …..……..……..……..…………… 
Passport country: ……..……..…..…..…….….….. Passport number: ……..……..…..…..…….….……..  
Arrival date: Day….…… Month….….  Year……. Birth date:    Day….…… Month….…..  Year………. 
Sex:  Male……… Female………   E-mail address: ……..………..………...……….…….   
Telephone number (include country code or country name): …..……..……......…......…............................  
Home address: ……..……..……..……..……..……..……..……..……..……..……..……..…….……..………  
Address for next 21 days: ……..……..……..……..……..……..……..……..……..……..…………………….. 
PUBLIC HEALTH INFORMATION: 
Today or in the past 48 hours, have you had any of the following symptoms? Yes No 
a. Fever (38° C / 100° F or higher), feeling feverish, or having chills?   
b. Vomiting or diarrhoea?   
c. Severe headaches or body aches?   
d. Unexplained bruising or bleeding?   
In the past 21 days, have you done any of the following? Yes No 
e. Lived in the same household or had other contact with a person sick with Ebola?   
f. Worked in a health-care facility treating Ebola patients or a laboratory analysing Ebola 
specimens, or touched the body of someone who died in a country with an Ebola 




List all countries where you have been in the past 21 days (including port transits and where you live). List 
the most recent country first (where you boarded). If you need more space, please use the back of the page.  
1………………………….………….…….  2………………………….…………………..  
 
3………………………….………….…….  4………………………….………………….. 
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Appendix 4: Secondary Screening Form 
 
**PLEASE ATTACH THE TRAVELLER PUBLIC HEALTH DECLARATION FORM USED FOR PRIMARY 
SCREENING TO THIS DOCUMENT 
 
Reason Individual Referred for Secondary Screening (Check All that Apply)*:  
 
 
SECTION 1: TRAVELLER INFORMATION 
 
Family name:____________________________ First name:__________________________________ 
Other name(s):_______________________________________________________________________            
Age: _____________  Date of Birth: _____/_____/________ (DD/MM/YYYY) Gender:  Male  Female       
Passport #: ______________________________ Passport Country:__________________________ 
Head of Household: _____________________ Village/Town: _________________ Parish: ___________ 
Country of Residence: ____________________ District: _________________ Sub-County: ________ 
 
Location where traveller became ill or had exposure:  
 
Village/Town: ___________________ District: ___________________ Sub-County: _______________ 
If different from permanent residence, dates residing at this location: ___/___/____ to ___/___/____ 
(DD/MM/YYYY) 
Date of Exposure (If Applicable): ____/____/________ (DD/MM/YYYY) 
 
SECTION 2: CLINICAL SIGNS AND SYMPTOMS 
Has the traveller experienced any of the following symptoms today OR within the past 48 hours? 
Date of First Symptom Onset: ____/____/________ (DD/MM/YYYY) 
 
Fever (≥38.6° C) □ Yes □ No □ Unk 
If yes, Onset date ____/____/________ (DD/MM/YYYY) 
Temp:____° C  
Vomiting/nausea □ Yes □ No □ Unk 
Diarrhoea □ Yes □ No □ Unk 
Intense fatigue/general weakness □ Yes □ No □ Unk 
Anorexia/loss of appetite □ Yes □ No □ Unk 
Abdominal pain □ Yes □ No □ Unk 
Chest pain □ Yes □ No □ Unk 
Muscle pain □ Yes □ No □ Unk 
Joint pain □ Yes □ No □ Unk 
Headache □ Yes □ No □ Unk 
Cough □ Yes □ No □ Unk 
Difficulty breathing □ Yes □ No □ Unk 
Difficulty swallowing □ Yes □ No □ Unk 
Sore throat □ Yes □ No □ Unk 
Jaundice (yellow eyes/gums/ 
skin) 
□ Yes □ No □ Unk 
Conjunctivitis (red eyes) □ Yes □ No □ Unk 
Skin rash □ Yes □ No □ Unk 
Pain behind eyes/sensitive to 
light 
□ Yes □ No □ Unk 
Confused or disoriented □ Yes □ No □ Unk 
Unexplained bleeding from any site □ Yes □ No □ Unk 
If yes: 
Bleeding of the gums □ Yes □ No □ Unk 
Bleeding from injection site □ Yes □ No □ Unk 
Nose bleed (epistaxis) □ Yes □ No □ Unk 
Blood or black stools (melena) □ Yes □ No □ Unk 
Fresh/red blood in vomit 
(haematemesis) 
□ Yes □ No □ Unk 
Coughing up blood (haemoptysis) □ Yes □ No □ Unk 
Bleeding from vagina, other than 
menstruation 
□ Yes □ No □ Unk 
Bruising of the skin 
(petechiae/ecchymosis) 
□ Yes □ No □ Unk 
Other haemorrhagic symptoms □ Yes □ No □ Unk 
If yes, please specify: ______________________________ 
________________________________________________ 
Other non-haemorrhagic clinical 
symptoms 
□ Yes □ No □ Unk 





Point of Entry/Departure:      
Date of Interview (DD/MM/YYYY):      
Temperature (°C):  
□ Fever □ Exposure(s)   
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SECTION 3: EXPOSURES AND RISK FACTORS 
 
Screening personnel should ask the following questions during the public health interview.  
In the past three weeks, have you been in any of the following situations? 
 
Were you exposed to the blood or other body fluids of a person with EVD?                                                            Yes  No  Unk 
If yes, did you ever NOT wear waterproof gloves, gown, facemask, and/or goggles?  Yes  No  Unk 
Did you get pricked with a needle or other sharp object, or splashed in the eye, nose, or 
mouth? 
 Yes  No  Unk 
Did you provide direct care to any person with EVD while the person was sick?  Yes  No  Unk 
If yes, did you ever NOT wear waterproof gloves, gown, facemask, and/or goggles?  Yes  No  Unk 
Did you work in a laboratory where body fluids of EVD patients were processed?  Yes  No  Unk 
If yes, did you ever NOT wear waterproof gloves, gown, facemask, and/or goggles?  Yes  No  Unk 
Did you directly handle dead bodies, such as participating in a funeral or burial rites or 
other activities that involve handling dead bodies?  
 Yes  No  Unk 
If yes, did you ever NOT wear waterproof gloves, gown, facemask, and/or goggles?  Yes  No  Unk 
Have you spent time in the same room as any person with EVD?   Yes  No  Unk 
If yes, did you ever NOT wear waterproof gloves, gown, facemask, and/or goggles?  Yes  No  Unk 
If yes, were you always at least 1 metre away from the person with EVD?  Yes  No  Unk 
If yes, did you spend a long period of time in the room (more than walking past the area)?  Yes  No  Unk 
If yes, did you have any physical contact with the person with EVD, such as shaking hands 
or touching any body part? 
 Yes  No  Unk 
Have you been interviewed as part of a contact-tracing investigation after an individual has 
been confirmed to have EVD? 
 Yes  No  Unk 
 
Unk = unknown 
 
SECTION 4: TRIAGE AND RESPONSE 
Complete the table with the measures to be taken based on the results of the assessment  
 
Travel Intervention (check one): Medical Assessment and Intervention (check all that apply): 
Contact Public Health Authority for all transported and referred 
travellers 
  
 Allowed to board flight   Transported to hospital/health-care facility  
 Not allowed to board flight  Referred home for symptom watch 
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Appendix 5: Travel Companion Listing Form  
  
*Please provide information on where the contact will be residing for the next month. 
 
 
**Types of contact with suspect case 
1 = Come into contact with the body fluids of the suspect case (blood, vomit, saliva, urine, faeces) 
2 = Had direct physical contact with the suspect case 
3 = Touched or shared the linens, clothes, or dishes/eating utensils of the suspect case 
4 = Slept, ate, or spent time in the same household as the suspect case 
5 = Travel companion 
 
TO BE COMPLETED BY SCREENER: 
Name: ___________________________________  Position: _____________________________  Phone: 
___________________________________
Suspect Case Information  
Surname Other name(s) Phone 
number 
Village/Town* Sub-county* District* Date of Symptoms 
Onset 
Dates of Travel* 
        
Companion Information     
Surname Other name(s) Phone 
number 
 






Type of contact 
(1,2,3,4,5)** 
with suspect 
case; list all 
          
          
          
          
          
          
          
Form ID: 
Point of entry: 




























































































Appendix 11: Sample Ill Traveller Card 
  
Information for Ill Travellers: Ebola 
What you need to do 
  
You have been given this card because you might have been exposed to patients with Ebola, and 
because you are sick with symptoms consistent with Ebola infection. This does not mean that you 
have Ebola, but further evaluation is needed.  
 Ebola is a severe, often fatal disease that spreads through direct contact with an infected 
person’s blood or body fluids (such as saliva or urine). Symptoms appear within 21 days of 
exposure.  
 People exposed to Ebola are not contagious unless they have a fever and other symptoms of 
Ebola: severe headache, muscle pain, vomiting, diarrhoea, stomach pain, or unexplained 
bleeding or bruising. 
 
Because of your exposure and symptoms, public health officials require that you be medically evaluated.  
   • You will be taken to a hospital emergency department. 
   • At the hospital, a doctor will examine you. Based on the results of the examination, you might be  
      tested for Ebola, if recommended by public health officials.   
   • Follow all instructions by public health and medical personnel to prevent exposing others. 
 
If your medical evaluation does not indicate Ebola infection:  
   • You will be allowed to leave the hospital. 
   • However, continue to take steps to protect yourself and others until 21 days after leaving the Ebola- 
      affected country: 
        o Take your temperature every morning and evening, and watch for symptoms consistent with  
            Ebola fever, severe headache, muscle pain, vomiting, diarrhoea, stomach pain, or unexplained  
            bleeding and bruising. 
        o Check in regularly with public health officials according to their instructions. 
        o Tell public health officials if you plan to travel more than 50 miles or to another country. 
        o Do not travel on commercial planes, ships or trains. 
        o Call public health officials immediately if you get a fever* or other symptoms.  
                *Fever: temperature of  38° C / 100.4° F or higher, or feeling like you have a fever. 
                • If you can’t reach a public health official, call a doctor. Tell the doctor where you travelled and 
that you might have been exposed to Ebola.  
                • Do not use public transport to get to the medical facility. Only travel by private car or  
                   ambulance. 
        o Bring this notice and give it to health-care staff when you arrive. 
 
(Sample text for travellers based on CDC recommendations. Adapt as necessary for protocol in 
country of use.) 
 
